[go: up one dir, main page]

010 Change Control1

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 26
At a glance
Powered by AI
The key takeaways are that changes need to be properly controlled and managed to ensure quality, efficacy and safety of pharmaceutical products. A change control process is necessary to evaluate impacts of changes and ensure regulatory compliance.

The document discusses changes that can be forced due to external factors like supplier issues or voluntary changes made for improvements. It also distinguishes between changes that are mandatory versus optional.

When evaluating a proposed change, factors like the risks and benefits, impact on quality and safety, validation status, and regulatory implications need to be considered. The views of relevant experts should also be obtained.

Management of Change

Control

Overview
Changes Good or bad? Forced or voluntary?
The Importance of Change Control
Major Changes to both legacy company documents
Scope and Responsibilities according to our new Directive
General Requirements
The Process with the detailed Requirements

Changes - Good or Bad?


A pharmaceutical company is built on both Quality and
Consistency
To always get the right product quality
To follow the established process

But a successful firm has also to perform changes


To make continuous improvements and implement innovations
To remain competitive and ultimately stay in business

Changes - Forced or Voluntary?

Some items must be changed where you have no option


Supplier cannot deliver the material
Raw material no longer available

Other items can be changed where we do have an option


Change of site, scale, or equipment
Change of QC test method

We need to consider the risk versus benefit of each change

But the biggest risk by far is an uncontrolled change

Even the smallest changes can cause very high risk if not
properly controlled

The Importance of Change


Control
Changes must be controlled, managed and followed
up to ensure that they are processed according to
GMP requirements and Health Authority regulations
This includes changes initiated by site or other
company internal decisions as well as changes
resulting from regulatory requests
The change control process must ensure quality,
efficacy and safety of the product throughout its life
cycle and updated regulatory files.

In other words : Change


Control
Process has

To evaluate the impact of proposed changes on the quality,


efficacy and safety of the final product

To evaluate the equivalence of changes of facilities,


equipment, manufacturing process, and technical transfer

To assess the impact on changing specifications and/or


analysis methods of all materials used

To determine appropriate actions before the change is


implemented

Scope

This scope applies to all manufacturing sites, affiliates and


subcontractors

It applies to all modifications of a product or a process


covering the following not limited to :

Raw materials (Change of suppliers, process, specs.)


Formula of drug products
Manufacturing process
Specifications and control procedures of components,
bulk and finished product
Primary packaging, storage and labelling
Medical devices
Equipment (incl. computerized automated systems)
Facilities, utilities and environment
GMP documentation (e.g., SOPs, MBR, batch records)

Responsibilities (1)
Site Management is responsible for ensuring that
any modification to their operations is
documented, evaluated and approved from a
technical, scientific, quality and regulatory point of
view
Site Quality Management along with other appropriate
functions are responsible for coordinating change
control activities in their respective areas to ensure
that there is an assessment of all proposed changes
and that approved changes are communicated to all
affected parties.

Responsibilities (2)
The site Quality Head is responsible for
ensuring that there are systems and
procedures to comply with applicable
Directives
The site Quality Head is responsible for
approving or rejecting a proposed change
at site level following an assessment by
the site Change Control Committee.

Responsibilities (3)
It is the responsibility of site Quality Management (QM) to ensure
that the regulatory evaluation assesses any potential impact the
change may have on the registration file
If the change has a potential regulatory impact, it is the
responsibility of the Regulatory Site Officer (RSO) to involve the
appropriate functions for further activities
If the change has a no regulatory impact, the implementation
/closing is handled by the site QM/RSO
For non-local products (i.e. products under the responsibility of
Corporate), the RSO is responsible to initiate the assessment of the
proposed change via the Corporate Change Control Committee

QM Responsibilities for Change


Control
QM is responsible for ensuring a robust
and easy to handle Change Control system
Defining clear roles and responsibilities
(initiator, reviewer, approver)
Creating a simple procedure with flow-charts
Defining the needed activities (internally and
externally)
Ensuring that all needed functions are involved
Training and education of all employees
involved

Change Control Management


needs Training

QM is responsible for managing the site Change Control


system

Change control is a topic in which every employee involved


in the manufacturing process needs to be trained

Good change control will be as good as the training and


education received

Focus the training on the serious potential for negative


impact of any uncontrolled change

We do not want anyone making unauthorised changes to


any activity that has Quality and/or Compliance impact

A Strong Reminder
Change made and intended to improve can result in a
worse situation or even in a disaster. Therefore, all
consequences must be considered
With a good change you can create other related
problems and also high amount of costs
Even minor changes or those that are considered to be
minor, can have a big impact to product quality and
regulatory compliance
And finally, all changes need to be closed-out.

General Requirements (1)


Any change, which can affect a product with
respect to its qualitative and/or quantitative
composition, quality (including bioavailability,
tolerance), purity, appearance, functionality
and/or stability must be assessed for its potential
impact prior to its implementation and processed
according the result of the assessment
There must be a procedure in place at the site for
periodic assessment that incremental changes
have not altered the overall process.

General Requirements (2)


The Corporate Change Control Committees must address all
changes with regulatory impact, evaluate all technical, quality
and regulatory aspects and decide
The Corporate Change Control Committees must decide on the :
Worldwide strategy based on the technical and/or scientific, quality and
regulatory information available at the Corporate Change Control
Committee level
Identification of Department/Person in charge of writing the dossier
Action plan including timelines until submission

More details later !

Initiation of the Change


Control
Request at the Site Level (1)

For an effective primary technical, scientific, quality and


regulatory evaluation, the following systems and
processes must be implemented :
An evaluation system which allows the assessment of all
changes proposed by the site on a regular basis. This
must include the creation of a change control committee
at site level involving appropriate site functions/experts
Use of a Change Control Request Form (CCRF) and followup tool (e.g. via electronic mails) as described in the
company procedure on change control.

Initiation of the Change


Control
Request at the Site Level (2)
The CCRF must be submitted to the sites change control
committee
Proposed changes must be justified by adequate and
sufficient supporting data and documentation must allow
complete understanding and the implications of the
planned change to ensure adequate assessment
The technical and/or scientific evaluation of the change is
under the responsibility of the concerned departments
(Technical, Production and/or Development departments)
at the site level.

Initiation of the Change


Control
Request at the Site Level (3)

The quality and regulatory evaluation is under the


responsibility of the Head of Quality and the site regulatory
officer. Advice provided by experts such as the regulatory
representative responsible for the product may be
requested

If the proposed change has a regulatory impact and is


approved by the Head of Quality, the completed CCRF must
be routed by Quality Management and site regulatory
officer to other appropriate functions outside the site for
coordination of a complete assessment of the technical
and/or scientific, quality and regulatory actions required to
enact the change, including timing of implementation.

Processing of the Change


Control
Request after Site Approval
(1)
Changes approved by the Head of Quality must
be supported by a detailed time and events
schedule that has been agreed upon by the
Change Control Committee or directly with
affiliate RAs

The Change Control Committee (CCC) addresses


all changes with regulatory impact for all active
pharmaceutical ingredients and all quality
changes that may have an impact for the
pharmaceutical product (ex: crystallography)

Processing of the Change


Control
Request after Site Approval
(2)
In all cases, the Committee must involve representatives of

appropriate functions competent to assess the proposed


change request with regards to technical and/or scientific,
quality and/or regulatory aspects in order to approve or to
reject the proposed change or to put the proposed change on
hold until supplementary information is made available

The Corporate Change Control Committees must decide on the


Worldwide strategy based on the technical and/or scientific, quality
and regulatory information available at Corporate Change Control
Committee level.
Identification of Department/Person in charge of the writing of the
dossier
Action plan including timelines until submission

Processing of the Change


Control
Request after Site Approval
(3)
Any modification of the change must

be
reported to the Committee through an
addendum of the initial CCRF for new
assessment

The Corporate Change Control Committees


decision should have a validity period of
typically 6 months. If a change is not
processed during this period, a new CCRF
must be initiated for re-assessment

Compilation of Documentation
Supporting
Changes with Regulatory Impact
On receipt of filled-in and signed-off CCRF from either Corporate
Change Control Committees or local Change Control Committees ,
the Affiliate Regulatory Affairs or regulatory site officer must prepare
or support the preparation of submission ready documents based on
the agreed regulatory assessment of the change and must provide
them to the appropriate regulatory function for review and approval
for file ability
The appropriate regulatory function must submit the provided
documentation to the appropriate Health Authorities
The Affiliate Regulatory Affairs or the site regulatory officer must
inform the change control committee, as applicable, of the receipt of
regulatory notification or approval or rejection of submitted changes.

Implementation of Changes
at Site Level (1)
For changes without regulatory impact, the site Change
Control Committee must decide about the prerequisites
and implementation timelines as well as informing the
respective unit in which the change will occur. A change
must only be implemented after receipt of the written
approval documented on the CCRF
For changes with regulatory impact, the release of the
batch after implementation of the change must only be
made after notification or approval of the submitted file
by the respective Health Authorities (except in case of
an annual reportable change for the US).

Implementation of Changes
at Site Level (2)
The regulatory site officer must
inform affiliate regulatory affairs of
the date of implementation of such a
change with the specific batch
number reference
The change request form must be
archived by site Quality Management.

Conclusion and Summary

Changes need to be traceable


Who changed, What, Where, When, Why, and How
What are the consequences with respect to risks and
costs, to validation status and submission to Authorities

Changes need to be planned in advance, evaluated,


approved, implemented and followed-up

The required experts need to be involved. Dont forget


engineers and IS people!

Documentation should be clear, accurate and complete

Keep you manufacturing process in the validated state/


state of control when you perform changes !

Thank You
Any Questions

You might also like